Cargando…
VEGF Paradoxically Reduces Cerebral Blood Flow in Alzheimer’s Disease Mice
Vascular dysfunction plays a critical role in the development of Alzheimer’s disease. Cerebral blood flow reductions of 10% to 25% present early in disease pathogenesis. Vascular Endothelial Growth Factor-A (VEGF-A) drives angiogenesis, which typically addresses blood flow reductions and global hypo...
Autores principales: | Ali, Muhammad, Bracko, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298729/ https://www.ncbi.nlm.nih.gov/pubmed/35873789 http://dx.doi.org/10.1177/26331055221109254 |
Ejemplares similares
-
VEGF signalling causes stalls in brain capillaries and reduces
cerebral blood flow in Alzheimer’s mice
por: Ali, Muhammad, et al.
Publicado: (2022) -
Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
por: Waragai, Masaaki, et al.
Publicado: (2020) -
A pilot study investigating the effects of voluntary exercise on capillary stalling and cerebral blood flow in the APP/PS1 mouse model of Alzheimer’s disease
por: Falkenhain, Kaja, et al.
Publicado: (2020) -
Cerebral blood flow in Alzheimer’s disease
por: Roher, Alex E, et al.
Publicado: (2012) -
High fat diet worsens Alzheimer’s disease-related behavioral abnormalities and neuropathology in APP/PS1 mice, but not by synergistically decreasing cerebral blood flow
por: Bracko, Oliver, et al.
Publicado: (2020)